GAM Holding’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $368K | Buy |
2,996
+210
| +8% | +$25.5K | 0.02% | 256 |
|
|
2025
Q3 | $309K | Buy |
+2,786
| New | +$317K | 0.02% | 260 |
|
|
2024
Q3 | – | Sell |
-71,090
| Closed | -$4.88M | – | 164 |
|
|
2024
Q2 | $4.88M | Buy |
71,090
+3,023
| +4% | +$202K | 0.37% | 76 |
|
|
2024
Q1 | $4.99M | Sell |
68,067
-5,662
| -8% | -$435K | 0.36% | 86 |
|
|
2023
Q4 | $5.97M | Hold |
73,729
| – | – | 0.44% | 74 |
|
|
2023
Q3 | $5.53M | Buy |
73,729
+31
| +0% | +$2.38K | 0.41% | 82 |
|
|
2023
Q2 | $5.68M | Sell |
73,698
-111
| -0.2% | -$8.85K | 0.39% | 86 |
|
|
2023
Q1 | $6.12M | Buy |
73,809
+578
| +0.8% | +$47.9K | 0.42% | 78 |
|
|
2022
Q4 | $6.29M | Sell |
73,231
-415
| -0.6% | -$32.9K | 0.5% | 69 |
|
|
2022
Q3 | $4.54M | Sell |
73,646
-29,539
| -29% | -$1.86M | 0.35% | 89 |
|
|
2022
Q2 | $6.38M | Sell |
103,185
-426
| -0.4% | -$26.4K | 0.42% | 72 |
|
|
2022
Q1 | $6.16M | Sell |
103,611
-13,818
| -12% | -$883K | 0.31% | 93 |
|
|
2021
Q4 | $8.53M | Sell |
117,429
-18,955
| -14% | -$1.31M | 0.38% | 78 |
|
|
2021
Q3 | $9.53M | Sell |
136,384
-5,821
| -4% | -$409K | 0.44% | 70 |
|
|
2021
Q2 | $9.79M | Buy |
142,205
+3,679
| +3% | +$246K | 0.42% | 74 |
|
|
2021
Q1 | $8.95M | Buy |
138,526
+90,138
| +186% | +$5.81M | 0.42% | 71 |
|
|
2020
Q4 | $2.82M | Sell |
48,388
-147,463
| -75% | -$8.9M | 0.17% | 147 |
|
|
2020
Q3 | $12.4M | Buy |
195,851
+153
| +0.1% | +$10.6K | 0.74% | 27 |
|
|
2020
Q2 | $15.1M | Sell |
195,698
-37,768
| -16% | -$2.89M | 0.94% | 19 |
|
|
2020
Q1 | $17.5M | Sell |
233,466
-54,582
| -19% | -$3.77M | 1.19% | 14 |
|
|
2019
Q4 | $18.7M | Buy |
288,048
+31,157
| +12% | +$2.03M | 0.88% | 19 |
|
|
2019
Q3 | $16.3M | Sell |
256,891
-25,107
| -9% | -$1.64M | 0.72% | 20 |
|
|
2019
Q2 | $19.1M | Buy |
281,998
+13,945
| +5% | +$917K | 0.74% | 14 |
|
|
2019
Q1 | $17.4M | Buy |
268,053
+48,330
| +22% | +$3.21M | 0.73% | 18 |
|
|
2018
Q4 | $13.7M | Sell |
219,723
-42,345
| -16% | -$2.96M | 0.7% | 24 |
|
|
2018
Q3 | $20.2M | Buy |
262,068
+2,020
| +0.8% | +$153K | 0.74% | 17 |
|
|
2018
Q2 | $18.4M | Sell |
260,048
-1,723
| -0.7% | -$122K | 0.64% | 19 |
|
|
2018
Q1 | $19.7M | Sell |
261,771
-14,193
| -5% | -$1.13M | 0.7% | 17 |
|
|
2017
Q4 | $19.8M | Buy |
275,964
+23,015
| +9% | +$1.75M | 0.61% | 21 |
|
|
2017
Q3 | $20.5M | Sell |
252,949
-646,820
| -72% | -$49.5M | 0.86% | 18 |
|
|
2017
Q2 | $63.7M | Buy |
899,769
+46,046
| +5% | +$3.06M | 0.94% | 10 |
|
|
2017
Q1 | $58M | Buy |
853,723
+35,516
| +4% | +$2.5M | 0.92% | 12 |
|
|
2016
Q4 | $58.6M | Buy |
818,207
+27,703
| +4% | +$2.06M | 1.03% | 9 |
|
|
2016
Q3 | $62.5M | Sell |
790,504
-39,095
| -5% | -$3.18M | 1.1% | 8 |
|
|
2016
Q2 | $69.2M | Buy |
829,599
+183,568
| +28% | +$16.3M | 1.07% | 7 |
|
|
2016
Q1 | $59.4M | Buy |
646,031
+56,973
| +10% | +$5.14M | 0.99% | 13 |
|
|
2015
Q4 | $59.6M | Buy |
589,058
+123,489
| +27% | +$12.8M | 0.93% | 13 |
|
|
2015
Q3 | $45.7M | Buy |
465,569
+7,656
| +2% | +$850K | 0.79% | 22 |
|
|
2015
Q2 | $53.6M | Buy |
457,913
+35,091
| +8% | +$3.83M | 0.78% | 18 |
|
|
2015
Q1 | $41.5M | Buy |
422,822
+46,143
| +12% | +$4.69M | 0.62% | 29 |
|
|
2014
Q4 | $35.5M | Sell |
376,679
-36,666
| -9% | -$3.79M | 0.53% | 40 |
|
|
2014
Q3 | $44M | Buy |
413,345
+79,308
| +24% | +$7.77M | 0.64% | 27 |
|
|
2014
Q2 | $27.7M | Sell |
334,037
-60,228
| -15% | -$4.69M | 0.42% | 62 |
|
|
2014
Q1 | $27.9M | Buy |
394,265
+51,633
| +15% | +$4.05M | 0.45% | 55 |
|
|
2013
Q4 | $25.7M | Sell |
342,632
-2,482
| -0.7% | -$173K | 0.45% | 54 |
|
|
2013
Q3 | $21.7M | Sell |
345,114
-16,318
| -5% | -$975K | 0.41% | 58 |
|
|
2013
Q2 | $18.5M | Buy |
+361,432
| New | +$18.8M | 0.4% | 60 |
|
Other funds holding GILD
GAM Holding's GILD Position: Q4 2025 in Review
GAM Holding increased its Gilead Sciences (GILD) stake by 7.5% in Q4 2025, buying an estimated $25.5K and bringing the position to 2,996 shares worth $368K. The position accounts for 0.02% of the portfolio, ranked #256.
GAM Holding first reported a position in GILD in Q2 2013 and has held it in 47 quarters since. The position peaked at $69.2M in Q2 2016. 2,216 funds tracked by Wall St. Rank hold GILD as of Q4 2025.
- GAM Holding held 2,996 shares of Gilead Sciences worth $368K as of Q4 2025.
- GAM Holding bought 210 Gilead Sciences shares in Q4 2025, an estimated $25.5K.
- Gilead Sciences made up 0.02% of GAM Holding's portfolio in Q4 2025, its #256 holding.
- GAM Holding first reported a position in Gilead Sciences in Q2 2013 and has held it in 47 quarters since.
- GAM Holding's Gilead Sciences position peaked at $69.2M in Q2 2016.
- 2,216 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.
Based on GAM Holding's 13F filing for Q4 2025, filed 17 Feb 2026.